Global Biosimilar Drug Sales Market Report 2021
Report Code: KNJ827577 No. of Pages: 133 Category: Pharmaceuticals and Healthcare
Publisher: Date of Publish:
Publisher: Date of Publish:
The global Biosimilar Drug market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Biosimilar Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.
Segment by Type
Injection
Tablets
Other Types
Segment by Application
Ankylosing Spondylitis
Tumor
Rheumatoid Arthrtis
Cardiovascular
Other Application
The Biosimilar Drug market is analysed and market size information is provided by regions (countries). Segment by Application, the Biosimilar Drug market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.
By Company
Amgen
Eli Lilly
Novartis
CP Guojian Pharma
Biotech Pharma
1 Biosimilar Drug Market Overview
1.1 Biosimilar Drug Product Scope
1.2 Biosimilar Drug Segment by Type
1.2.1 Global Biosimilar Drug Sales by Type (2016 & 2021 & 2027)
1.2.2 Injection
1.2.3 Tablets
1.2.4 Other Types
1.3 Biosimilar Drug Segment by Application
1.3.1 Global Biosimilar Drug Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Ankylosing Spondylitis
1.3.3 Tumor
1.3.4 Rheumatoid Arthrtis
1.3.5 Cardiovascular
1.3.6 Other Application
1.4 Biosimilar Drug Market Estimates and Forecasts (2016-2027)
1.4.1 Global Biosimilar Drug Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Biosimilar Drug Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Biosimilar Drug Price Trends (2016-2027)
2 Biosimilar Drug Estimates and Forecasts by Region
2.1 Global Biosimilar Drug Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Biosimilar Drug Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Biosimilar Drug Sales Market Share by Region (2016-2021)
2.2.2 Global Biosimilar Drug Revenue Market Share by Region (2016-2021)
2.3 Global Biosimilar Drug Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Biosimilar Drug Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Biosimilar Drug Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Biosimilar Drug Estimates and Projections (2016-2027)
2.4.2 Europe Biosimilar Drug Estimates and Projections (2016-2027)
2.4.3 China Biosimilar Drug Estimates and Projections (2016-2027)
2.4.4 Japan Biosimilar Drug Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Biosimilar Drug Estimates and Projections (2016-2027)
2.4.6 India Biosimilar Drug Estimates and Projections (2016-2027)
3 Global Biosimilar Drug Competition Landscape by Players
3.1 Global Top Biosimilar Drug Players by Sales (2016-2021)
3.2 Global Top Biosimilar Drug Players by Revenue (2016-2021)
3.3 Global Biosimilar Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Biosimilar Drug as of 2020)
3.4 Global Biosimilar Drug Average Price by Company (2016-2021)
3.5 Manufacturers Biosimilar Drug Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Biosimilar Drug Market Size by Type
4.1 Global Biosimilar Drug Historic Market Review by Type (2016-2021)
4.1.1 Global Biosimilar Drug Sales Market Share by Type (2016-2021)
4.1.2 Global Biosimilar Drug Revenue Market Share by Type (2016-2021)
4.1.3 Global Biosimilar Drug Price by Type (2016-2021)
4.2 Global Biosimilar Drug Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Biosimilar Drug Sales Forecast by Type (2022-2027)
4.2.2 Global Biosimilar Drug Revenue Forecast by Type (2022-2027)
4.2.3 Global Biosimilar Drug Price Forecast by Type (2022-2027)
5 Global Biosimilar Drug Market Size by Application
5.1 Global Biosimilar Drug Historic Market Review by Application (2016-2021)
5.1.1 Global Biosimilar Drug Sales Market Share by Application (2016-2021)
5.1.2 Global Biosimilar Drug Revenue Market Share by Application (2016-2021)
5.1.3 Global Biosimilar Drug Price by Application (2016-2021)
5.2 Global Biosimilar Drug Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Biosimilar Drug Sales Forecast by Application (2022-2027)
5.2.2 Global Biosimilar Drug Revenue Forecast by Application (2022-2027)
5.2.3 Global Biosimilar Drug Price Forecast by Application (2022-2027)
6 North America Biosimilar Drug Market Facts & Figures
6.1 North America Biosimilar Drug Sales by Company
6.1.1 North America Biosimilar Drug Sales by Company (2016-2021)
6.1.2 North America Biosimilar Drug Revenue by Company (2016-2021)
6.2 North America Biosimilar Drug Sales Breakdown by Type
6.2.1 North America Biosimilar Drug Sales Breakdown by Type (2016-2021)
6.2.2 North America Biosimilar Drug Sales Breakdown by Type (2022-2027)
6.3 North America Biosimilar Drug Sales Breakdown by Application
6.3.1 North America Biosimilar Drug Sales Breakdown by Application (2016-2021)
6.3.2 North America Biosimilar Drug Sales Breakdown by Application (2022-2027)
7 Europe Biosimilar Drug Market Facts & Figures
7.1 Europe Biosimilar Drug Sales by Company
7.1.1 Europe Biosimilar Drug Sales by Company (2016-2021)
7.1.2 Europe Biosimilar Drug Revenue by Company (2016-2021)
7.2 Europe Biosimilar Drug Sales Breakdown by Type
7.2.1 Europe Biosimilar Drug Sales Breakdown by Type (2016-2021)
7.2.2 Europe Biosimilar Drug Sales Breakdown by Type (2022-2027)
7.3 Europe Biosimilar Drug Sales Breakdown by Application
7.3.1 Europe 133 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 133 Sales Breakdown by Application (2022-2027)
8 China Biosimilar Drug Market Facts & Figures
8.1 China Biosimilar Drug Sales by Company
8.1.1 China Biosimilar Drug Sales by Company (2016-2021)
8.1.2 China Biosimilar Drug Revenue by Company (2016-2021)
8.2 China Biosimilar Drug Sales Breakdown by Type
8.2.1 China Biosimilar Drug Sales Breakdown by Type (2016-2021)
8.2.2 China Biosimilar Drug Sales Breakdown by Type (2022-2027)
8.3 China Biosimilar Drug Sales Breakdown by Application
8.3.1 China 242 Sales Breakdown by Application (2016-2021)
8.3.2 China 242 Sales Breakdown by Application (2022-2027)
9 Japan Biosimilar Drug Market Facts & Figures
9.1 Japan Biosimilar Drug Sales by Company
9.1.1 Japan Biosimilar Drug Sales by Company (2016-2021)
9.1.2 Japan Biosimilar Drug Revenue by Company (2016-2021)
9.2 Japan Biosimilar Drug Sales Breakdown by Type
9.2.1 Japan Biosimilar Drug Sales Breakdown by Type (2016-2021)
9.2.2 Japan Biosimilar Drug Sales Breakdown by Type (2022-2027)
9.3 Japan Biosimilar Drug Sales Breakdown by Application
9.3.1 Japan Jan. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Jan. Sales Breakdown by Application (2022-2027)
10 Southeast Asia Biosimilar Drug Market Facts & Figures
10.1 Southeast Asia Biosimilar Drug Sales by Company
10.1.1 Southeast Asia Biosimilar Drug Sales by Company (2016-2021)
10.1.2 Southeast Asia Biosimilar Drug Revenue by Company (2016-2021)
10.2 Southeast Asia Biosimilar Drug Sales Breakdown by Type
10.2.1 Southeast Asia Biosimilar Drug Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Biosimilar Drug Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Biosimilar Drug Sales Breakdown by Application
10.3.1 Southeast Asia K Dose Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia K Dose Sales Breakdown by Application (2022-2027)
11 India Biosimilar Drug Market Facts & Figures
11.1 India Biosimilar Drug Sales by Company
11.1.1 India Biosimilar Drug Sales by Company (2016-2021)
11.1.2 India Biosimilar Drug Revenue by Company (2016-2021)
11.2 India Biosimilar Drug Sales Breakdown by Type
11.2.1 India Biosimilar Drug Sales Breakdown by Type (2016-2021)
11.2.2 India Biosimilar Drug Sales Breakdown by Type (2022-2027)
11.3 India Biosimilar Drug Sales Breakdown by Application
11.3.1 India Biosimilar Drug Sales Breakdown by Application (2016-2021)
11.3.2 India Biosimilar Drug Sales Breakdown by Application (2022-2027)
12 Company Profiles and Key Figures in Biosimilar Drug Business
12.1 Amgen
12.1.1 Amgen Corporation Information
12.1.2 Amgen Business Overview
12.1.3 Amgen Biosimilar Drug Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Amgen Biosimilar Drug Products Offered
12.1.5 Amgen Recent Development
12.2 Eli Lilly
12.2.1 Eli Lilly Corporation Information
12.2.2 Eli Lilly Business Overview
12.2.3 Eli Lilly Biosimilar Drug Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Eli Lilly Biosimilar Drug Products Offered
12.2.5 Eli Lilly Recent Development
12.3 Novartis
12.3.1 Novartis Corporation Information
12.3.2 Novartis Business Overview
12.3.3 Novartis Biosimilar Drug Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Novartis Biosimilar Drug Products Offered
12.3.5 Novartis Recent Development
12.4 CP Guojian Pharma
12.4.1 CP Guojian Pharma Corporation Information
12.4.2 CP Guojian Pharma Business Overview
12.4.3 CP Guojian Pharma Biosimilar Drug Sales, Revenue and Gross Margin (2016-2021)
12.4.4 CP Guojian Pharma Biosimilar Drug Products Offered
12.4.5 CP Guojian Pharma Recent Development
12.5 Biotech Pharma
12.5.1 Biotech Pharma Corporation Information
12.5.2 Biotech Pharma Business Overview
12.5.3 Biotech Pharma Biosimilar Drug Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Biotech Pharma Biosimilar Drug Products Offered
12.5.5 Biotech Pharma Recent Development
...
13 Biosimilar Drug Manufacturing Cost Analysis
13.1 Biosimilar Drug Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Biosimilar Drug
13.4 Biosimilar Drug Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Biosimilar Drug Distributors List
14.3 Biosimilar Drug Customers
15 Market Dynamics
15.1 Biosimilar Drug Market Trends
15.2 Biosimilar Drug Drivers
15.3 Biosimilar Drug Market Challenges
15.4 Biosimilar Drug Market Restraints
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
NEED Help?
If you need any help or guidance, please feel free to call us.
USA : +1 (661) 636 6162
INDIA : +91 9325802062
or
Write us on : sales@kandjmarketresearch.com